Gossamer Bio, Inc. (GOSS) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Omega Fund V, L.P. mit 6,553,416 Aktien. Weitere bedeutende Anteilseigner sind Hasnain Faheem und Aranda Richard.
In den letzten 12 Monaten haben Insider 16 Transaktionen in GOSS Aktien getätigt — 10 Käufe (im Wert von $938.4K) und 0 Verkäufe (im Wert von RSU Award). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
GOSS Insider-Beteiligungen
Größter Aktionär
Omega Fund V, L.P.
6,553,416 Aktien
Käufe (12 Monate)
10
$938.4K Wert
Verkäufe (12 Monate)
0
$0.00 Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Omega Fund V, L.p. |
10 Percent Owner |
6,553,416 |
2019-09-23 |
|
| 2 |
Hasnain Faheem |
President & CEO |
837,793 |
2026-01-05 |
|
| 3 |
Aranda Richard |
Chief Medical Officer |
463,106 |
2026-01-05 |
|
| 4 |
Peterson Caryn |
EVP, Regulatory Affairs |
440,000 |
2025-03-06 |
|
| 5 |
Christian Waage |
EVP, Tech Ops and Admin |
440,000 |
2025-03-06 |
|
| 6 |
Giraudo Bryan |
COO/cfo |
389,737 |
2026-01-05 |
|
| 7 |
Smith Robert Paul Jr |
Chief Commercial Officer |
260,898 |
2026-01-05 |
|
| 8 |
Salter-cid Luisa |
Chief Scientific Officer |
206,065 |
2021-03-25 |
|
| 9 |
Gujrathi Sheila |
President & CEO |
189,500 |
2020-02-19 |
|
| 10 |
Milligan Sandra |
Director |
115,000 |
2025-06-26 |
|
| 11 |
Cox Russell J. |
Director |
115,000 |
2025-06-26 |
|
| 12 |
Drynan Skye |
Director |
115,000 |
2025-06-26 |
|
| 13 |
Quisel John D |
Director |
115,000 |
2025-06-26 |
|
| 14 |
Nathan Steven D |
Director |
115,000 |
2025-06-26 |
|
| 15 |
Daniel Thomas O |
Director |
115,000 |
2025-06-26 |
|
| 16 |
Carter Laura |
Chief Scientific Officer |
76,263 |
2023-03-20 |
|
| 17 |
Dupont Jakob |
Chief Medical Officer |
46,500 |
2020-02-19 |
|
| 18 |
Burow Kristina |
Director |
35,000 |
2023-06-09 |
|
| 19 |
Gala Renee D |
Director |
35,000 |
2023-06-09 |
|
| 20 |
Bilenker Joshua H. |
Director |
30,000 |
2022-07-15 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-19 |
Smith Robert Paul Jr |
Chief Commercial Officer |
Aktienrückgabe |
562,500 |
$2.88 |
$1.62M |
| 2026-03-19 |
Aranda Richard |
Chief Medical Officer |
Aktienrückgabe |
157,500 |
$1.21 |
$190.58K |
| 2026-03-19 |
Peterson Caryn |
EVP, Regulatory Affairs |
Aktienrückgabe |
125,000 |
$0.84 |
$104.75K |
| 2026-03-19 |
Giraudo Bryan |
COO/cfo |
Aktienrückgabe |
211,500 |
$2.16 |
$456.84K |
| 2026-03-19 |
Christian Waage |
EVP, Tech Ops and Admin |
Aktienrückgabe |
70,000 |
$1.36 |
$95.2K |
| 2026-03-19 |
Hasnain Faheem |
President & CEO |
Aktienrückgabe |
47,000 |
$12.10 |
$568.7K |
| 2026-01-02 |
Smith Robert Paul Jr |
Chief Commercial Officer |
RSU-Zuteilung |
93,750 |
- |
- |
| 2026-01-02 |
Aranda Richard |
Chief Medical Officer |
RSU-Zuteilung |
93,750 |
- |
- |
| 2026-01-02 |
Giraudo Bryan |
COO/cfo |
RSU-Zuteilung |
115,750 |
- |
- |
| 2026-01-02 |
Hasnain Faheem |
President & CEO |
RSU-Zuteilung |
280,000 |
- |
- |
| 2025-06-25 |
Nathan Steven D |
Director |
RSU-Zuteilung |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Drynan Skye |
Director |
RSU-Zuteilung |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Milligan Sandra |
Director |
RSU-Zuteilung |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Quisel John D |
Director |
RSU-Zuteilung |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Daniel Thomas O |
Director |
RSU-Zuteilung |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Cox Russell J. |
Director |
RSU-Zuteilung |
115,000 |
$1.36 |
$156.4K |
